CLINICAL_TRIALS
trial_result
· 2014-08-12
Clinical Trial Update: A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093 [Phase 2]
Summary
A phase 2, placebo-controlled trial evaluating the safety and efficacy of BIA 2-093 in epilepsy has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2014-08-12